SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study

SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study

Summary: Background: Solid-organ transplant (SOT) recipients have worse COVID-19 outcomes than general population and effective immunisation in these patients is essential but more difficult to reach. We aimed to determine the immunogenicity of an mRNA SARS-CoV-2 vaccine booster in SOT recipients p...

Full description

Bibliographic Details
Main Authors: Martín Dib, Nicole Le Corre, Catalina Ortiz, Daniel García, Marcela Ferrés, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, María José Ojeda, Manuel A. Espinoza, Aquiles Jara, Juan Pablo Arab, Ricardo Rabagliati, Cecilia Vizcaya, María Elena Ceballos, Mauricio Sarmiento, Sebastián Mondaca, Macarena Viñuela, Antonia Pastore, Vania Szwarcfiter, Elizabeth Galdames, Aldo Barrera, Pablo Castro, Nicolás MS Gálvez, Jorge A. Soto, Susan M. Bueno, Alexis M. Kalergis, Bruno Nervi, M. Elvira Balcells
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:The Lancet Regional Health. Americas
Subjects:
SARS-CoV-2
COVID-19
Vaccine
CoronaVac
BNT162b2
Solid organ transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X22001880

Internet

http://www.sciencedirect.com/science/article/pii/S2667193X22001880

Similar Items